<p>(A) Oral glucose tolerance and (B) insulin tolerance tests were performed on ND (black circles), ND + CORM-3 (black triangles), HFD (black squares) and HFD + CORM-3 (white diamonds) mice. Data are means ± SEM. n = 10 in each group. (a) p<0.05 between HFD and ND; (b) p<0.05 between HFD + CORM-3 and ND. (C) Plasma cholesterol and (D) true triglyceride measurements were performed on 6–10 different samples in each group. Data are means ± SEM. (E) Basal oxygen uptake (<i>V</i>O<sub>2</sub>) and carbon dioxide rejection (<i>V</i>CO<sub>2</sub>), (F) respiratory exchange ratio (RER). Data represent means ± SEM. n = 5–7 in each group, * p<0.05 vs. ND. White bars = ND; vertically hatched bars = ND + CORM-3; black bars = HFD; crosshatched ...
AIMS: Metabolic syndrome induces cardiac dysfunction associated with mitochondria abnormalities. As ...
<p>(A) Results of quantitative RT-PCR detecting <i>Ucp2</i> and <i>Ucp3</i> mRNA expressions. Result...
ABSTRACT: Chronic, low level treatment with a carbon monoxide releasing molecule (CO-RM), CORM-A1, h...
<p>(A) Left Ventricular Developed Pressure (LVDP) of hearts isolated from normal diet (ND) or high-f...
Macrophage-to-plasma m-RCT was increased in diabetic mice, and liver-to-feces m-RCT was decreased in...
<p>Plasma concentrations of corticosterone, insulin, leptin, fibroblast growth factor 21 (FGF21), tr...
Antinociceptive effects produced by the intraperitoneal administration of CORM-2 at 5 or 10 mg/kg in...
Altres ajuts: La Marató grant number 201602-31 to JJ.The antinociceptive effects of the carbon monox...
<p>Mice were challenged with CLP and treated with CORM-2 as described in <a href="http://www.plosone...
The antinociceptive effects of the carbon monoxide-releasing molecule tricarbonyldichlororuthenium (...
<div><h3>Aims</h3><p>Metabolic syndrome induces cardiac dysfunction associated with mitochondria abn...
Background/Aims: Carbon monoxide (CO) interferes with cytochrome-dependent cellular functions and ac...
<p>(A) Schematic representation of the dietary interventions. (B) Analysis of body weight in mice fe...
(A) Representative diene formation curves of human LDL alone or incubated with HDL isolated from mic...
<p>HUVECs were grown to confluence in 48-well cell culture plates and were stimulated with LPS (10 µ...
AIMS: Metabolic syndrome induces cardiac dysfunction associated with mitochondria abnormalities. As ...
<p>(A) Results of quantitative RT-PCR detecting <i>Ucp2</i> and <i>Ucp3</i> mRNA expressions. Result...
ABSTRACT: Chronic, low level treatment with a carbon monoxide releasing molecule (CO-RM), CORM-A1, h...
<p>(A) Left Ventricular Developed Pressure (LVDP) of hearts isolated from normal diet (ND) or high-f...
Macrophage-to-plasma m-RCT was increased in diabetic mice, and liver-to-feces m-RCT was decreased in...
<p>Plasma concentrations of corticosterone, insulin, leptin, fibroblast growth factor 21 (FGF21), tr...
Antinociceptive effects produced by the intraperitoneal administration of CORM-2 at 5 or 10 mg/kg in...
Altres ajuts: La Marató grant number 201602-31 to JJ.The antinociceptive effects of the carbon monox...
<p>Mice were challenged with CLP and treated with CORM-2 as described in <a href="http://www.plosone...
The antinociceptive effects of the carbon monoxide-releasing molecule tricarbonyldichlororuthenium (...
<div><h3>Aims</h3><p>Metabolic syndrome induces cardiac dysfunction associated with mitochondria abn...
Background/Aims: Carbon monoxide (CO) interferes with cytochrome-dependent cellular functions and ac...
<p>(A) Schematic representation of the dietary interventions. (B) Analysis of body weight in mice fe...
(A) Representative diene formation curves of human LDL alone or incubated with HDL isolated from mic...
<p>HUVECs were grown to confluence in 48-well cell culture plates and were stimulated with LPS (10 µ...
AIMS: Metabolic syndrome induces cardiac dysfunction associated with mitochondria abnormalities. As ...
<p>(A) Results of quantitative RT-PCR detecting <i>Ucp2</i> and <i>Ucp3</i> mRNA expressions. Result...
ABSTRACT: Chronic, low level treatment with a carbon monoxide releasing molecule (CO-RM), CORM-A1, h...